← Eichor
Study identifier: NCT07186192 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Digital Health Intervention for Self-Management and Telemonitoring in Chimeric Antigen Receptor (CAR-T) Therapy

Condition: Hematologic Malignancies  ·  Sponsor: City of Hope Medical Center

PhasePhase 3
Planned participants190
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

The overall purpose of this randomized control trial (RCT) is to determine the clinical effect of a multilevel, RPM-enhanced intervention during and after completion of outpatient CAR-T therapy in 190 patients and their family caregivers (FCGs).

This description comes directly from the study's public registry record.

Talk to the study team

Virginia Sun, PhD, RN  ·  626-218-3122  ·  vsun@coh.org

Always discuss trial participation with your own doctor first.

Locations (1)

City of Hope Medical CenterDuarte, California, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07186192